Perindopril Erbumine Tablet
Pricing Report NDC 65862-286-01

Current NADAC: $0.48838 per EA · Effective Sep 23, 2026 · Est. package price $48.84 (100 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Perindopril Erbumine (NDC 65862-286-01) is $0.48838 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Aurobindo Pharma Limited, this medication is distributed in a 100 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.48838
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 23, 2026
Billable Units
100 EA
Estimated Package Price
$48.84
Data Status
As of Oct 07, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
65862-286-01
Description
100 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2025, the NADAC wholesale price for (NDC ) has moved within a range of $0.41872 to $0.53634 per EA. Over this 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4187 - $0.5363
Market Volatility
28.09% Variance
Latest Trend
16.61%
DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $0.48838 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 22, 2026 $0.41882 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 22, 2026 $0.41882 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Jun 17, 2026 $0.41882 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 20, 2026 $0.41872 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 22, 2026 $0.44440 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 18, 2026 $0.45299 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 18, 2026 $0.47095 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 21, 2026 $0.49301 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 17, 2025 $0.51506 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 19, 2025 $0.53634 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Oct 22, 2025 $0.53634 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026